A quality-by-design optimized LC method for navigating degradation kinetics and quantification of favipiravir in the presence of degradation products and manufacturing impurities
Abstract Emergent viruses require effective treatment regimens, and the severe acute respiratory syndrome coronavirus-2 variants are still evolving. Favipiravir has emerged as an effective antiviral medication, especially after its popularity against COVID-2019. Despite its growing popularity, favip...
Saved in:
| Main Authors: | Adel Ehab Ibrahim, Mohamed Farouk, Samy G. Alamir, Baher I. Salman, Tarek S. Belal, Sami El Deeb, Ahmed Al-Harrasi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Chemistry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13065-025-01610-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RP-HPLC method development and validation of Abacavir, Lamivudine and Zidovudine in combined pharmaceutical dosage by analytical QbD
by: Divyesh Vanparia, et al.
Published: (2025-04-01) -
Formulation Optimization, Physicochemical Characterization, and Biocompatibility Assessment of Curcumin‐Loaded Aquasomes
by: Fernando Bwalya, et al.
Published: (2025-06-01) -
Stability-indicating UPLC method for quantification of alpelisib in bulk and tablet formulation by QbD approach
by: Tandrima Majumder, et al.
Published: (2025-04-01) -
Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma
by: T. N. Komarov, et al.
Published: (2022-09-01) -
Quality by Design (QbD)-Driven Development and Optimization of Tacrolimus-Loaded Microemulsion for the Treatment of Skin Inflammation
by: Sanjida Ahmed Srishti, et al.
Published: (2024-11-01)